(Q35073894)

6 August 2017

1 reference

title

Hepatic resection in the treatment of perihilar cholangiocarcinoma (English)

1 reference

6 August 2017

0 references

Juan M Sarmiento

1

1 reference

PubMed ID

12607578

6 August 2017

David M Nagorney

series ordinal

2

1 reference

PubMed ID

12607578

6 August 2017

language of work or name

1 reference

1 October 2002

1 reference

Surgical oncology clinics of North America

6 August 2017

1 reference

6 August 2017

11

1 reference

6 August 2017

4

1 reference

6 August 2017

893-908, viii-ix

1 reference

6 August 2017

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Sclerosing carcinoma of the major intrahepatic bile ducts

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

CONGENITAL HEMOLYTIC JAUNDICE CORRECTED BY SPLENECTOMY FOLLOWED TWENTY-SIX YEARS LATER BY BLEEDING TENDENCY, HEPATOMEGALY AND SUDDEN DEATH

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Pathological aspects of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Cholangiocarcinoma complicating primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Management Strategies in Resection for Hilar Cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Multidisciplinary management of perihilar bile duct cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Portal vein evaluation with US: comparison to angiography combined with CT arterial portography

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Portal vein embolization: rationale, technique and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Preoperative portal vein embolization: An audit of 84 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Tumor seeding from percutaneous biliary catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Combined portal vein and liver resection for carcinoma of the biliary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Management of Proximal cholangiocarcinomas by surgical resection and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Surgical treatment for hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Surgery for hilar cholangiocarcinoma: an Italian experience

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

One hundred and eleven liver resections for hilar bile duct cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Extended resections for hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900034-0

7 January 2021

10.1016/S1055-3207(02)00034-0

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12607578